Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Activation of Notch1 signaling is required for β-catenin–mediated human primary melanoma progression
Klara Balint, … , Meenhard Herlyn, Zhao-Jun Liu
Klara Balint, … , Meenhard Herlyn, Zhao-Jun Liu
Published November 1, 2005
Citation Information: J Clin Invest. 2005;115(11):3166-3176. https://doi.org/10.1172/JCI25001.
View: Text | PDF
Research Article Oncology

Activation of Notch1 signaling is required for β-catenin–mediated human primary melanoma progression

  • Text
  • PDF
Abstract

Notch is a highly conserved transmembrane receptor that determines cell fate. Notch signaling denotes cleavage of the Notch intracellular domain, its translocation to the nucleus, and subsequent activation of target gene transcription. Involvement of Notch signaling in several cancers is well known, but its role in melanoma remains poorly characterized. Here we show that the Notch1 pathway is activated in human melanoma. Blocking Notch signaling suppressed whereas constitutive activation of the Notch1 pathway enhanced primary melanoma cell growth both in vitro and in vivo yet had little effect on metastatic melanoma cells. Activation of Notch1 signaling enabled primary melanoma cells to gain metastatic capability. Furthermore, the oncogenic effect of Notch1 on primary melanoma cells was mediated by β-catenin, which was upregulated following Notch1 activation. Inhibiting β-catenin expression reversed Notch1-enhanced tumor growth and metastasis. Our data therefore suggest a β-catenin–dependent, stage-specific role for Notch1 signaling in promoting the progression of primary melanoma.

Authors

Klara Balint, Min Xiao, Chelsea C. Pinnix, Akinobu Soma, Imre Veres, Istvan Juhasz, Eric J. Brown, Anthony J. Capobianco, Meenhard Herlyn, Zhao-Jun Liu

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Constitutive activation of Notch1 pathway enhances melanoma growth in vi...
Constitutive activation of Notch1 pathway enhances melanoma growth in vitro. (A) Cells were transfected with either NIC-GFP or GFP. Equal numbers of stable transfectants were plated and photographed after 4 hours under fluorescence microscopy. Scale bar: 20 μm. More than 95% of green cells were observed in all other melanoma cell lines. (B) Upper panel shows COS7 cells transfected with NIC-GFP or GFP lentiviruses were analyzed by Northern (left) and Western (right) blot. NIC gene and protein expression are shown. 28S rRNA and β-actin were used as controls for Northern and Western blots, respectively. Lower panel shows expression of activated Notch1 in melanoma transfectants as detected by Western blot. (C) Cell growth was measured by 3[H]-thymidine incorporation assays. Ectopic expression of NIC accelerated primary melanoma but did not affect metastatic melanoma cell growth. Data were normalized by setting the activities of GFP-transfected control cells at 100. Results are mean ± SD from triplicates in 3 independent experiments. *P < 0.005, Student’s t test. (D) Percentage of colonies formed in soft agar. NIC enhances colony formation of primary but not metastatic melanoma cells. **Note that colonies formed by WM3248-NIC-GFP cells are larger than those of control, although the numbers are not significantly increased. Data were normalized by setting the activities of GFP-transfected control cells as 100. Results are mean ± SD from independent experiments. #P < 0.001, Student’s t test. (E) Representative fields in soft agar plates. Scale bar: 500 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts